Target intelligence / Profile preview

Eukaryotic large ribosomal subunit (60S) (60S ribosomal subunit)

Target
60S ribosomal subunit
Molecular classification
Ribosome component, Ribonucleoprotein complex, Other
01

Overview

The eukaryotic large ribosomal subunit (60S) is an essential component of the cytosolic 80S ribosome in eukaryotes. It consists of three rRNA molecules—28S, 5.8S, and 5S rRNAs—and approximately 47–49 proteins. The primary function of the 60S subunit is to catalyze peptide bond formation during protein synthesis via its peptidyl transferase center—a reaction fundamental for translating mRNA into polypeptides. The structure also contains sites for tRNA binding and forms part of the exit tunnel through which nascent polypeptides emerge. Drugs such as cycloheximide inhibit its activity by blocking elongation during translation. While it shares functional similarities with the prokaryotic large (50S) subunit, it is larger and more complex due to additional RNA expansion segments and unique proteins found only in eukaryotes. Disruption or dysregulation can contribute to diseases such as cancer or rare inherited disorders known as ribosomopathies. Because global inhibition leads to cell death across tissues, direct pharmacological targeting carries significant safety concerns except under controlled experimental conditions.

Other names
60S ribosomal subunitLarge ribosomal subunit (eukaryotic)Eukaryotic 60SRibosome 60S subunit
02

Mechanism of action

Inhibition of peptide bond formation by binding to the peptidyl transferase center

03

Biological functions

Protein synthesis (translation)Peptide bond formationmRNA translation regulation
04

Disease associations

Cancer (altered protein synthesis is a hallmark in many cancers)Infection (target of some antibiotics and toxins)Other (ribosomopathies, rare genetic disorders affecting ribosome function)
05

Safety considerations

Global inhibition of protein synthesis leads to cytotoxicity in all dividing cells; thus, targeting this structure therapeutically has high toxicity risk.
06

Interacting drugs

Cycloheximide

1 more in the full profile.

Beyond the preview

Go deeper on Eukaryotic large ribosomal subunit (60S) (60S ribosomal subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic large ribosomal subunit (60S) (60S ribosomal subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call